Sareum Holdings Plc (LON:SAR) fell 8.6% during mid-day trading on Tuesday . The company traded as low as GBX 0.37 ($0.00) and last traded at GBX 0.37 ($0.00), 3,165,493 shares changed hands during mid-day trading. A decline of 49% from the average session volume of 6,230,000 shares. The stock had previously closed at GBX 0.41 ($0.01).
The firm has a market cap of $11.36 million and a P/E ratio of -3.70. The company’s fifty day moving average is GBX 0.43.
Sareum Company Profile (LON:SAR)
Sareum Holdings plc engages in the discovery and development of therapeutic drugs to treat cancer and autoimmune diseases. It develops therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's product pipeline includes Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2 kinase.
Further Reading: Trading based on a resistance level
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.